首页 > 最新文献

EGEMS (Washington, DC)最新文献

英文 中文
Implementing a Novel Quality Improvement-Based Approach to Data Quality Monitoring and Enhancement in a Multipurpose Clinical Registry. 在多用途临床注册中实现一种新的基于质量改进的数据质量监测和增强方法。
Pub Date : 2019-09-30 DOI: 10.5334/egems.262
Jesse Pratt, Daniel Jeffers, Eileen C King, Michael D Kappelman, Jennifer Collins, Peter Margolis, Howard Baron, Julie A Bass, Mikelle D Bassett, Genie L Beasley, Keith J Benkov, Jeffrey A Bornstein, José M Cabrera, Wallace Crandall, Liz D Dancel, Monica P Garin-Laflam, John E Grunow, Barry Z Hirsch, Edward Hoffenberg, Esther Israel, Traci W Jester, Fevronia Kiparissi, Arathi Lakhole, Sameer P Lapsia, Phillip Minar, Fernando A Navarro, Haley Neef, K T Park, Dinesh S Pashankar, Ashish S Patel, Victor M Pineiro, Charles M Samson, Kelly C Sandberg, Steven J Steiner, Jennifer A Strople, Boris Sudel, Jillian S Sullivan, David L Suskind, Vikas Uppal, Prateek D Wali

Objective: To implement a quality improvement based system to measure and improve data quality in an observational clinical registry to support a Learning Healthcare System.

Data source: ImproveCareNow Network registry, which as of September 2019 contained data from 314,250 visits of 43,305 pediatric Inflammatory Bowel Disease (IBD) patients at 109 participating care centers.

Study design: The impact of data quality improvement support to care centers was evaluated using statistical process control methodology. Data quality measures were defined, performance feedback of those measures using statistical process control charts was implemented, and reports that identified data items not following data quality checks were developed to enable centers to monitor and improve the quality of their data.

Principal findings: There was a pattern of improvement across measures of data quality. The proportion of visits with complete critical data increased from 72 percent to 82 percent. The percent of registered patients improved from 59 percent to 83 percent. Of three additional measures of data consistency and timeliness, one improved performance from 42 percent to 63 percent. Performance declined on one measure due to changes in network documentation practices and maturation. There was variation among care centers in data quality.

Conclusions: A quality improvement based approach to data quality monitoring and improvement is feasible and effective.

目的:实施一个基于质量改进的系统,以测量和提高观察性临床注册中心的数据质量,从而支持学习型医疗保健系统。数据来源:ImproveCareNow网络注册中心,截至2019年9月,该注册中心包含109个参与护理中心43305名儿童炎症性肠病(IBD)患者的314250次就诊数据。研究设计:使用统计过程控制方法评估数据质量改进支持对护理中心的影响。定义了数据质量指标,使用统计过程控制图对这些指标进行了绩效反馈,并制定了确定未遵循数据质量检查的数据项的报告,以使各中心能够监测和提高其数据质量。主要发现:在数据质量衡量标准方面存在改进模式。具有完整关键数据的就诊比例从72%增加到82%。注册患者的百分比从59%提高到83%。在另外三项衡量数据一致性和及时性的指标中,有一项将性能从42%提高到63%。由于网络文档实践和成熟度的变化,一项指标的性能下降。各护理中心的数据质量存在差异。结论:基于质量改进的数据质量监测和改进方法是可行和有效的。
{"title":"Implementing a Novel Quality Improvement-Based Approach to Data Quality Monitoring and Enhancement in a Multipurpose Clinical Registry.","authors":"Jesse Pratt, Daniel Jeffers, Eileen C King, Michael D Kappelman, Jennifer Collins, Peter Margolis, Howard Baron, Julie A Bass, Mikelle D Bassett, Genie L Beasley, Keith J Benkov, Jeffrey A Bornstein, José M Cabrera, Wallace Crandall, Liz D Dancel, Monica P Garin-Laflam, John E Grunow, Barry Z Hirsch, Edward Hoffenberg, Esther Israel, Traci W Jester, Fevronia Kiparissi, Arathi Lakhole, Sameer P Lapsia, Phillip Minar, Fernando A Navarro, Haley Neef, K T Park, Dinesh S Pashankar, Ashish S Patel, Victor M Pineiro, Charles M Samson, Kelly C Sandberg, Steven J Steiner, Jennifer A Strople, Boris Sudel, Jillian S Sullivan, David L Suskind, Vikas Uppal, Prateek D Wali","doi":"10.5334/egems.262","DOIUrl":"10.5334/egems.262","url":null,"abstract":"<p><strong>Objective: </strong>To implement a quality improvement based system to measure and improve data quality in an observational clinical registry to support a Learning Healthcare System.</p><p><strong>Data source: </strong>ImproveCareNow Network registry, which as of September 2019 contained data from 314,250 visits of 43,305 pediatric Inflammatory Bowel Disease (IBD) patients at 109 participating care centers.</p><p><strong>Study design: </strong>The impact of data quality improvement support to care centers was evaluated using statistical process control methodology. Data quality measures were defined, performance feedback of those measures using statistical process control charts was implemented, and reports that identified data items not following data quality checks were developed to enable centers to monitor and improve the quality of their data.</p><p><strong>Principal findings: </strong>There was a pattern of improvement across measures of data quality. The proportion of visits with complete critical data increased from 72 percent to 82 percent. The percent of registered patients improved from 59 percent to 83 percent. Of three additional measures of data consistency and timeliness, one improved performance from 42 percent to 63 percent. Performance declined on one measure due to changes in network documentation practices and maturation. There was variation among care centers in data quality.</p><p><strong>Conclusions: </strong>A quality improvement based approach to data quality monitoring and improvement is feasible and effective.</p>","PeriodicalId":72880,"journal":{"name":"EGEMS (Washington, DC)","volume":"7 1","pages":"51"},"PeriodicalIF":0.0,"publicationDate":"2019-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777196/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41222007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Spatial Analysis of Health Disparities Associated with Antibiotic Resistant Infections in Children Living in Atlanta (2002–2010) 亚特兰大儿童抗生素耐药性感染相关健康差异的空间分析(2002-2010)
Pub Date : 2019-09-12 DOI: 10.5334/egems.308
Fatima Ali, L. Immergluck, T. Leong, L. Waller, K. Malhotra, R. Jerris, M. Edelson, G. Rust
Background: Antibiotic resistant bacteria like community-onset methicillin resistant Staphylococcus aureus (CO-MRSA) have continued to cause infections in children at alarming rates and are associated with health disparities. Geospatial analyses of individual and area level data can enhance disease surveillance and identify socio-demographic and geographic indicators to explain CO-MRSA disease transmission patterns and risks. Methods: A case control epidemiology approach was undertaken to compare children with CO-MRSA to a noninfectious condition (unintentional traumatic brain injury (uTBI)). In order to better understand the impact of place based risks in developing these types of infections, data from electronic health records (EHR) were obtained from CO-MRSA cases and compared to EHR data from controls (uTBI). US Census data was used to determine area level data. Multi-level statistical models were performed using risk factors determined a priori and geospatial analyses were conducted and mapped. Results: From 2002–2010, 4,613 with CO-MRSA and 34,758 with uTBI were seen from two pediatric hospitals in Atlanta, Georgia. Hispanic children had reduced odds of infection; females and public health insurance were more likely to have CO-MRSA. Spatial analyses indicate significant ‘hot spots’ for CO-MRSA and the overall spatial cluster locations, differed between CO-MRSA cases and uTBI controls. Conclusions: Differences exist in race, age, and type of health insurance between CO-MRSA cases compared to noninfectious control group. Geographic clustering of cases is distinct from controls, suggesting placed based factors impact risk for CO-MRSA infection.
背景:抗生素耐药性细菌,如社区发病的耐甲氧西林金黄色葡萄球菌(CO-MRSA),继续以惊人的速度导致儿童感染,并与健康差异有关。对个人和地区层面数据的地理空间分析可以加强疾病监测,并确定社会人口和地理指标,以解释耐甲氧西林金黄色葡萄球菌疾病传播模式和风险。方法:采用病例对照流行病学方法,将CO-MRSA儿童与非感染性疾病(非故意创伤性脑损伤(uTBI))进行比较。为了更好地了解基于地点的风险对这些类型感染的影响,从CO-MRSA病例中获得了电子健康记录(EHR)的数据,并与对照组(uTBI)的EHR数据进行了比较。美国人口普查数据用于确定地区层面的数据。使用事先确定的风险因素进行了多级统计模型,并进行了地理空间分析和绘制了地图。结果:从2002年到2010年,佐治亚州亚特兰大的两家儿科医院共发现4613例CO-MRSA患者和34758例uTBI患者。西班牙裔儿童感染的几率降低;女性和公共医疗保险更有可能患有耐甲氧西林金黄色葡萄球菌。空间分析表明,CO-MRSA的显著“热点”和总体空间聚类位置在CO-MRSA病例和uTBI对照组之间有所不同。结论:与非感染对照组相比,CO-MRSA病例在种族、年龄和医疗保险类型方面存在差异。病例的地理聚类与对照组不同,这表明基于位置的因素影响CO-MRSA感染的风险。
{"title":"A Spatial Analysis of Health Disparities Associated with Antibiotic Resistant Infections in Children Living in Atlanta (2002–2010)","authors":"Fatima Ali, L. Immergluck, T. Leong, L. Waller, K. Malhotra, R. Jerris, M. Edelson, G. Rust","doi":"10.5334/egems.308","DOIUrl":"https://doi.org/10.5334/egems.308","url":null,"abstract":"Background: Antibiotic resistant bacteria like community-onset methicillin resistant Staphylococcus aureus (CO-MRSA) have continued to cause infections in children at alarming rates and are associated with health disparities. Geospatial analyses of individual and area level data can enhance disease surveillance and identify socio-demographic and geographic indicators to explain CO-MRSA disease transmission patterns and risks. Methods: A case control epidemiology approach was undertaken to compare children with CO-MRSA to a noninfectious condition (unintentional traumatic brain injury (uTBI)). In order to better understand the impact of place based risks in developing these types of infections, data from electronic health records (EHR) were obtained from CO-MRSA cases and compared to EHR data from controls (uTBI). US Census data was used to determine area level data. Multi-level statistical models were performed using risk factors determined a priori and geospatial analyses were conducted and mapped. Results: From 2002–2010, 4,613 with CO-MRSA and 34,758 with uTBI were seen from two pediatric hospitals in Atlanta, Georgia. Hispanic children had reduced odds of infection; females and public health insurance were more likely to have CO-MRSA. Spatial analyses indicate significant ‘hot spots’ for CO-MRSA and the overall spatial cluster locations, differed between CO-MRSA cases and uTBI controls. Conclusions: Differences exist in race, age, and type of health insurance between CO-MRSA cases compared to noninfectious control group. Geographic clustering of cases is distinct from controls, suggesting placed based factors impact risk for CO-MRSA infection.","PeriodicalId":72880,"journal":{"name":"EGEMS (Washington, DC)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47147073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Predicting the Incidence of Pressure Ulcers in the Intensive Care Unit Using Machine Learning 利用机器学习预测重症监护室压疮的发病率
Pub Date : 2019-09-05 DOI: 10.5334/egems.307
E. Cramer, Martin G. Seneviratne, H. Sharifi, Alp Ozturk, T. Hernandez-Boussard
Background: Reducing hospital-acquired pressure ulcers (PUs) in intensive care units (ICUs) has emerged as an important quality metric for health systems internationally. Limited work has been done to characterize the profile of PUs in the ICU using observational data from the electronic health record (EHR). Consequently, there are limited EHR-based prognostic tools for determining a patient’s risk of PU development, with most institutions relying on nurse-calculated risk scores such as the Braden score to identify high-risk patients. Methods and Results: Using EHR data from 50,851 admissions in a tertiary ICU (MIMIC-III), we show that the prevalence of PUs at stage 2 or above is 7.8 percent. For the 1,690 admissions where a PU was recorded on day 2 or beyond, we evaluated the prognostic value of the Braden score measured within the first 24 hours. A high-risk Braden score (<=12) had precision 0.09 and recall 0.50 for the future development of a PU. We trained a range of machine learning algorithms using demographic parameters, diagnosis codes, laboratory values and vitals available from the EHR within the first 24 hours. A weighted linear regression model showed precision 0.09 and recall 0.71 for future PU development. Classifier performance was not improved by integrating Braden score elements into the model. Conclusion: We demonstrate that an EHR-based model can outperform the Braden score as a screening tool for PUs. This may be a useful tool for automatic risk stratification early in an admission, helping to guide quality protocols in the ICU, including the allocation and timing of prophylactic interventions.
背景:在重症监护室(ICU)减少医院获得性压疮(PU)已成为国际卫生系统的一项重要质量指标。使用电子健康记录(EHR)的观察数据来描述ICU中PU的特征的工作有限。因此,用于确定患者PU发展风险的基于EHR的预后工具有限,大多数机构依赖护士计算的风险评分,如Braden评分来识别高危患者。方法和结果:使用来自50851名三级ICU(MIMIC-III)患者的EHR数据,我们发现2期或以上PUs的患病率为7.8%。对于1690例在第2天或之后记录PU的入院患者,我们评估了在前24小时内测量的Braden评分的预后价值。高危Braden评分(<=12)对PU未来发展的准确度为0.09,召回率为0.50。我们在最初的24小时内使用EHR提供的人口统计参数、诊断代码、实验室值和生命体征训练了一系列机器学习算法。加权线性回归模型显示,未来PU开发的精确度为0.09,召回率为0.71。将Braden分数元素集成到模型中并没有提高分类器的性能。结论:我们证明了基于EHR的模型作为PU的筛查工具可以优于Braden评分。这可能是在入院早期自动进行风险分层的有用工具,有助于指导ICU的质量协议,包括预防性干预的分配和时间安排。
{"title":"Predicting the Incidence of Pressure Ulcers in the Intensive Care Unit Using Machine Learning","authors":"E. Cramer, Martin G. Seneviratne, H. Sharifi, Alp Ozturk, T. Hernandez-Boussard","doi":"10.5334/egems.307","DOIUrl":"https://doi.org/10.5334/egems.307","url":null,"abstract":"Background: Reducing hospital-acquired pressure ulcers (PUs) in intensive care units (ICUs) has emerged as an important quality metric for health systems internationally. Limited work has been done to characterize the profile of PUs in the ICU using observational data from the electronic health record (EHR). Consequently, there are limited EHR-based prognostic tools for determining a patient’s risk of PU development, with most institutions relying on nurse-calculated risk scores such as the Braden score to identify high-risk patients. Methods and Results: Using EHR data from 50,851 admissions in a tertiary ICU (MIMIC-III), we show that the prevalence of PUs at stage 2 or above is 7.8 percent. For the 1,690 admissions where a PU was recorded on day 2 or beyond, we evaluated the prognostic value of the Braden score measured within the first 24 hours. A high-risk Braden score (<=12) had precision 0.09 and recall 0.50 for the future development of a PU. We trained a range of machine learning algorithms using demographic parameters, diagnosis codes, laboratory values and vitals available from the EHR within the first 24 hours. A weighted linear regression model showed precision 0.09 and recall 0.71 for future PU development. Classifier performance was not improved by integrating Braden score elements into the model. Conclusion: We demonstrate that an EHR-based model can outperform the Braden score as a screening tool for PUs. This may be a useful tool for automatic risk stratification early in an admission, helping to guide quality protocols in the ICU, including the allocation and timing of prophylactic interventions.","PeriodicalId":72880,"journal":{"name":"EGEMS (Washington, DC)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49315176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 50
Applying a Commercialization-Readiness Framework to Optimize Value for Achieving Sustainability of an Electronic Health Data Research Network and Its Data Capabilities: The SAFTINet Experience. 应用商业化准备框架优化价值以实现电子健康数据研究网络及其数据能力的可持续性:SAFENet经验。
Pub Date : 2019-08-29 DOI: 10.5334/egems.295
Elaine H Morrato, Mika K Hamer, Marion Sills, Bethany Kwan, Lisa M Schilling

Context: Sustaining electronic health data networks and maximizing return on federal investment in their development is essential for achieving national data insight goals for transforming health care. However, crossing the business model chasm from grant funding to self-sustaining viability is challenging.

Case description: This paper presents lessons learned in seeking the sustainability of the Scalable Architecture for Federated Translational Inquiries Network (SAFTINet), and electronic health data network involving over 50 primary care practices in three states. SAFTINet was developed with funding from the Agency for Healthcare Research and Quality to create a multi-state network for comparative effectiveness research (CER) involving safety-net patients.

Methods: Three analyses were performed: (1) a product gap analysis of alternative data sources; (2) a Strengths-Weaknesses-Opportunities-Threat (SWOT) analysis of SAFTINet in the context of competing alternatives; and (3) a customer discovery process involving approximately 150 SAFTINet stakeholders to identify SAFTINet's sustaining value proposition for health services researchers, clinical data partners, and policy makers.

Findings: The results of this business model analysis informed SAFTINet's sustainability strategy. The fundamental high-level product needs were similar between the three primary customer segments: credible data, efficient and easy to use, and relevance to their daily work or 'jobs to be done'. However, how these benefits needed to be minimally demonstrated varied by customer such that different supporting evidence was required.

Major themes: The SAFTINet experience illustrates that commercialization-readiness and business model methods can be used to identify multi-sided value propositions for sustaining electronic health data networks and their data capabilities as drivers of health care transformation.

背景:维持电子健康数据网络并最大限度地提高其开发中的联邦投资回报,对于实现国家数据洞察目标以转变医疗保健至关重要。然而,跨越从赠款到自我维持生存能力的商业模式鸿沟是一项挑战。案例描述:本文介绍了在寻求联邦转化查询网络可扩展架构(SAFENet)和电子健康数据网络的可持续性方面所吸取的经验教训,该网络涉及三个州的50多家初级保健机构。SAFENet是在医疗保健研究与质量局的资助下开发的,旨在创建一个涉及安全网患者的多州比较有效性研究网络。方法:进行三项分析:(1)替代数据源的产品差距分析;(2) 在竞争性备选方案的背景下,对SAFENet的优势、劣势、机会、威胁(SWOT)分析;以及(3)涉及大约150名SAFENet利益相关者的客户发现过程,以确定SAFENet对健康服务研究人员、临床数据合作伙伴和政策制定者的持续价值主张。调查结果:该商业模式分析的结果为SAFENet的可持续发展战略提供了依据。三个主要客户群体的基本高级产品需求相似:可靠的数据、高效易用以及与日常工作或“待完成的工作”的相关性。然而,客户需要如何最低限度地证明这些好处各不相同,因此需要不同的支持证据。主要主题:SAFENet的经验表明,商业化准备和商业模式方法可用于确定维持电子健康数据网络的多方面价值主张及其作为医疗保健转型驱动因素的数据能力。
{"title":"Applying a Commercialization-Readiness Framework to Optimize Value for Achieving Sustainability of an Electronic Health Data Research Network and Its Data Capabilities: The SAFTINet Experience.","authors":"Elaine H Morrato, Mika K Hamer, Marion Sills, Bethany Kwan, Lisa M Schilling","doi":"10.5334/egems.295","DOIUrl":"10.5334/egems.295","url":null,"abstract":"<p><strong>Context: </strong>Sustaining electronic health data networks and maximizing return on federal investment in their development is essential for achieving national data insight goals for transforming health care. However, crossing the business model chasm from grant funding to self-sustaining viability is challenging.</p><p><strong>Case description: </strong>This paper presents lessons learned in seeking the sustainability of the Scalable Architecture for Federated Translational Inquiries Network (SAFTINet), and electronic health data network involving over 50 primary care practices in three states. SAFTINet was developed with funding from the Agency for Healthcare Research and Quality to create a multi-state network for comparative effectiveness research (CER) involving safety-net patients.</p><p><strong>Methods: </strong>Three analyses were performed: (1) a product gap analysis of alternative data sources; (2) a Strengths-Weaknesses-Opportunities-Threat (SWOT) analysis of SAFTINet in the context of competing alternatives; and (3) a customer discovery process involving approximately 150 SAFTINet stakeholders to identify SAFTINet's sustaining value proposition for health services researchers, clinical data partners, and policy makers.</p><p><strong>Findings: </strong>The results of this business model analysis informed SAFTINet's sustainability strategy. The fundamental high-level product needs were similar between the three primary customer segments: credible data, efficient and easy to use, and relevance to their daily work or 'jobs to be done'. However, how these benefits needed to be minimally demonstrated varied by customer such that different supporting evidence was required.</p><p><strong>Major themes: </strong>The SAFTINet experience illustrates that commercialization-readiness and business model methods can be used to identify multi-sided value propositions for sustaining electronic health data networks and their data capabilities as drivers of health care transformation.</p>","PeriodicalId":72880,"journal":{"name":"EGEMS (Washington, DC)","volume":"7 1","pages":"48"},"PeriodicalIF":0.0,"publicationDate":"2019-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715936/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41221969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovative Data Science to Transform Health Care: All the Pieces Matter 创新数据科学改变医疗保健:一切都很重要
Pub Date : 2019-08-28 DOI: 10.5334/egems.314
A. Masica, J. Escarce
This issue of eGEMS focuses on application of data science as a driver of health care transformation. Importantly, quantitative or qualitative analysis with a particular method is only one downstream step in the process of leveraging data. Effective analytics occurs on a continuum with multiple complementary phases, categorized here as data acquisition, ensuring or enhancing data access and usability, data analysis, and dissemination. Each of these activities is encompassed in the series of papers presented.
本期eGEMS关注数据科学作为医疗保健转型驱动因素的应用。重要的是,使用特定方法进行定量或定性分析只是利用数据过程中的一个下游步骤。有效的分析是在一个具有多个互补阶段的连续体上进行的,在这里分类为数据获取、确保或增强数据访问和可用性、数据分析和传播。这些活动中的每一项都包含在所提交的一系列文件中。
{"title":"Innovative Data Science to Transform Health Care: All the Pieces Matter","authors":"A. Masica, J. Escarce","doi":"10.5334/egems.314","DOIUrl":"https://doi.org/10.5334/egems.314","url":null,"abstract":"This issue of eGEMS focuses on application of data science as a driver of health care transformation. Importantly, quantitative or qualitative analysis with a particular method is only one downstream step in the process of leveraging data. Effective analytics occurs on a continuum with multiple complementary phases, categorized here as data acquisition, ensuring or enhancing data access and usability, data analysis, and dissemination. Each of these activities is encompassed in the series of papers presented.","PeriodicalId":72880,"journal":{"name":"EGEMS (Washington, DC)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49153639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Age-Dependent Hemoglobin A1c Therapeutic Targets Reduce Diabetic Medication Changes in the Elderly. 年龄依赖性糖化血红蛋白治疗靶点降低老年人糖尿病药物变化
Pub Date : 2019-08-26 DOI: 10.5334/egems.303
Thomas A McCormick, John L Adams, Eric A Lee, Nicholas P Emptage, Darryl E Palmer-Toy, John P Martin, Benjamin I Broder, Michael H Kanter, Anna C Davis, Elizabeth A McGlynn

Objective: To assess whether implementation of age-dependent therapeutic targets for high hemoglobin A1c (HbA1c) changed clinicians' ordering of diabetes medications for older adults.

Background: In 2016, Kaiser Permanente Southern California (KPSC) changed the therapeutic targets for alerting clinicians about high HbA1c results in the electronic health record, KP HealthConnect (KPHC). Previously, all HbA1c results ≥7.0 percent were flagged as high in adult patients with diabetes. Starting in 2016, HbA1c therapeutic targets were relaxed to <7.5 percent for patients age 65 to 75, and to <8.0 percent for patients over age 75 to reduce treatment intensity and adverse events.

Methods: This retrospective analysis used logistic regression models to calculate the change in odds of a medication change following an HbA1c result after age-dependent HbA1c flags were introduced.

Results: The odds of medication change decreased among patients whose HbA1c targets were relaxed: Odds Ratio (OR) 0.72 (95 percent CI 0.67-0.76) for patients age 65-75 and HbA1c 7.0 percent-7.5 percent; OR 0.72 (95 percent CI 0.65-0.80) for patients over age 75 and HbA1c 7.0 percent-7.5 percent; and OR 0.67 (95 percent CI 0.61-0.75) for patients over age 75 and HbA1c 7.5 percent-8.0 percent. In the age and HbA1c ranges for which the alerts did not change, the odds of medication change generally increased or stayed the same. There was little evidence of medication de-intensification in any group.

Conclusions: These findings suggest that the change in therapeutic targets was associated with a reduction in medication intensification among older adults with diabetes.

目的:评估高糖化血红蛋白(HbA1c)年龄依赖性治疗靶点的实施是否会改变临床医生对老年人糖尿病药物的处方。背景:2016年,Kaiser Permanente Southern California (KPSC)改变了电子健康记录KP HealthConnect (KPHC)中提醒临床医生高HbA1c结果的治疗目标。以前,成年糖尿病患者的所有HbA1c结果≥7.0%被标记为高。从2016年开始,65 - 75岁患者的HbA1c治疗目标放宽至< 7.5%,75岁以上患者的HbA1c治疗目标放宽至< 8.0%,以降低治疗强度和不良事件。方法:本回顾性分析使用逻辑回归模型计算在引入年龄相关HbA1c标志后HbA1c结果后药物改变的几率变化。结果:在HbA1c目标放宽的患者中,药物改变的几率降低:65-75岁患者的优势比(OR)为0.72 (95% CI 0.67-0.76), HbA1c为7.0% - 7.5%;75岁以上患者的OR为0.72 (95% CI 0.65-0.80), HbA1c为7.0% - 7.5%;75岁以上患者的OR为0.67 (95% CI 0.61-0.75), HbA1c为7.5% - 8.0%。在警报没有改变的年龄和HbA1c范围内,药物改变的几率通常增加或保持不变。几乎没有证据表明在任何一组中都有药物去强化。结论:这些发现表明,在老年糖尿病患者中,治疗靶点的改变与药物强化的减少有关。
{"title":"Age-Dependent Hemoglobin A1c Therapeutic Targets Reduce Diabetic Medication Changes in the Elderly.","authors":"Thomas A McCormick, John L Adams, Eric A Lee, Nicholas P Emptage, Darryl E Palmer-Toy, John P Martin, Benjamin I Broder, Michael H Kanter, Anna C Davis, Elizabeth A McGlynn","doi":"10.5334/egems.303","DOIUrl":"10.5334/egems.303","url":null,"abstract":"<p><strong>Objective: </strong>To assess whether implementation of age-dependent therapeutic targets for high hemoglobin A1c (HbA1c) changed clinicians' ordering of diabetes medications for older adults.</p><p><strong>Background: </strong>In 2016, Kaiser Permanente Southern California (KPSC) changed the therapeutic targets for alerting clinicians about high HbA1c results in the electronic health record, KP HealthConnect (KPHC). Previously, all HbA1c results ≥7.0 percent were flagged as high in adult patients with diabetes. Starting in 2016, HbA1c therapeutic targets were relaxed to <7.5 percent for patients age 65 to 75, and to <8.0 percent for patients over age 75 to reduce treatment intensity and adverse events.</p><p><strong>Methods: </strong>This retrospective analysis used logistic regression models to calculate the change in odds of a medication change following an HbA1c result after age-dependent HbA1c flags were introduced.</p><p><strong>Results: </strong>The odds of medication change decreased among patients whose HbA1c targets were relaxed: Odds Ratio (OR) 0.72 (95 percent CI 0.67-0.76) for patients age 65-75 and HbA1c 7.0 percent-7.5 percent; OR 0.72 (95 percent CI 0.65-0.80) for patients over age 75 and HbA1c 7.0 percent-7.5 percent; and OR 0.67 (95 percent CI 0.61-0.75) for patients over age 75 and HbA1c 7.5 percent-8.0 percent. In the age and HbA1c ranges for which the alerts did not change, the odds of medication change generally increased or stayed the same. There was little evidence of medication de-intensification in any group.</p><p><strong>Conclusions: </strong>These findings suggest that the change in therapeutic targets was associated with a reduction in medication intensification among older adults with diabetes.</p>","PeriodicalId":72880,"journal":{"name":"EGEMS (Washington, DC)","volume":" ","pages":"46"},"PeriodicalIF":0.0,"publicationDate":"2019-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715934/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44632276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracting Patient-Centered Outcomes from Clinical Notes in Electronic Health Records: Assessment of Urinary Incontinence After Radical Prostatectomy 从电子健康记录中提取以患者为中心的结果:前列腺癌根治术后尿失禁的评估
Pub Date : 2019-08-20 DOI: 10.5334/EGEMS.297
D. Gori, I. Banerjee, B. Chung, M. Ferrari, P. Rucci, D. Blayney, J. Brooks, T. Hernandez-Boussard
Objective: To assess documentation of urinary incontinence (UI) in prostatectomy patients using unstructured clinical notes from Electronic Health Records (EHRs). Methods: We developed a weakly-supervised natural language processing tool to extract assessments, as recorded in unstructured text notes, of UI before and after radical prostatectomy in a single academic practice across multiple clinicians. Validation was carried out using a subset of patients who completed EPIC-26 surveys before and after surgery. The prevalence of UI as assessed by EHR and EPIC-26 was compared using repeated-measures ANOVA. The agreement of reported UI between EHR and EPIC-26 was evaluated using Cohen’s Kappa coefficient. Results: A total of 4870 patients and 716 surveys were included. Preoperative prevalence of UI was 12.7 percent. Postoperative prevalence was 71.8 percent at 3 months, 50.2 percent at 6 months and 34.4 and 41.8 at 12 and 24 months, respectively. Similar rates were recorded by physicians in the EHR, particularly for early follow-up. For all time points, the agreement between EPIC-26 and the EHR was moderate (all p < 0.001) and ranged from 86.7 percent agreement at baseline (Kappa = 0.48) to 76.4 percent agreement at 24 months postoperative (Kappa = 0.047). Conclusions: We have developed a tool to assess documentation of UI after prostatectomy using EHR clinical notes. Our results suggest such a tool can facilitate unbiased measurement of important PCOs using real-word data, which are routinely recorded in EHR unstructured clinician notes. Integrating PCO information into clinical decision support can help guide shared treatment decisions and promote patient-valued care.
目的:使用电子健康记录(EHRs)中的非结构化临床记录来评估前列腺切除术患者尿失禁(UI)的记录。方法:我们开发了一种弱监督的自然语言处理工具,在多个临床医生的单一学术实践中,提取根治性前列腺切除术前后UI的评估,如非结构化文本注释中所记录的。使用在手术前后完成EPIC-26调查的患者子集进行验证。使用重复测量ANOVA比较EHR和EPIC-26评估的UI患病率。使用Cohen的Kappa系数评估EHR和EPIC-26之间报告的UI的一致性。结果:共纳入4870名患者和716项调查。术前UI发生率为12.7%。术后3个月的患病率为71.8%,6个月为50.2%,12个月和24个月分别为34.4和41.8。EHR中的医生也记录了类似的发病率,尤其是早期随访。在所有时间点,EPIC-26和EHR之间的一致性是中等的(均p<0.001),从基线时的86.7%一致性(Kappa=0.48)到术后24个月时的76.4%一致性(Kapa=0.047)。结论:我们已经开发了一种使用EHR临床记录来评估前列腺切除术后UI的工具。我们的研究结果表明,这种工具可以使用真实单词数据来促进重要PCO的无偏测量,这些数据通常记录在EHR非结构化临床医生笔记中。将多囊卵巢综合征信息整合到临床决策支持中,有助于指导共享治疗决策,促进患者重视护理。
{"title":"Extracting Patient-Centered Outcomes from Clinical Notes in Electronic Health Records: Assessment of Urinary Incontinence After Radical Prostatectomy","authors":"D. Gori, I. Banerjee, B. Chung, M. Ferrari, P. Rucci, D. Blayney, J. Brooks, T. Hernandez-Boussard","doi":"10.5334/EGEMS.297","DOIUrl":"https://doi.org/10.5334/EGEMS.297","url":null,"abstract":"Objective: To assess documentation of urinary incontinence (UI) in prostatectomy patients using unstructured clinical notes from Electronic Health Records (EHRs). Methods: We developed a weakly-supervised natural language processing tool to extract assessments, as recorded in unstructured text notes, of UI before and after radical prostatectomy in a single academic practice across multiple clinicians. Validation was carried out using a subset of patients who completed EPIC-26 surveys before and after surgery. The prevalence of UI as assessed by EHR and EPIC-26 was compared using repeated-measures ANOVA. The agreement of reported UI between EHR and EPIC-26 was evaluated using Cohen’s Kappa coefficient. Results: A total of 4870 patients and 716 surveys were included. Preoperative prevalence of UI was 12.7 percent. Postoperative prevalence was 71.8 percent at 3 months, 50.2 percent at 6 months and 34.4 and 41.8 at 12 and 24 months, respectively. Similar rates were recorded by physicians in the EHR, particularly for early follow-up. For all time points, the agreement between EPIC-26 and the EHR was moderate (all p < 0.001) and ranged from 86.7 percent agreement at baseline (Kappa = 0.48) to 76.4 percent agreement at 24 months postoperative (Kappa = 0.047). Conclusions: We have developed a tool to assess documentation of UI after prostatectomy using EHR clinical notes. Our results suggest such a tool can facilitate unbiased measurement of important PCOs using real-word data, which are routinely recorded in EHR unstructured clinician notes. Integrating PCO information into clinical decision support can help guide shared treatment decisions and promote patient-valued care.","PeriodicalId":72880,"journal":{"name":"EGEMS (Washington, DC)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42520292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Beyond CHNAS: Performance Measurement for Community Health Improvement. 超越CHNAS:社区健康改善的绩效衡量。
Pub Date : 2019-08-20 DOI: 10.5334/egems.312
Michael A Stoto, Mary V Davis, Abby Atkins

Research objective: Non-profit hospitals are required to work with community organizations to prepare Community Health Needs Assessment (CHNA) and implementation strategy (IS). In concert with the health care delivery system's transformation from volume to value and efforts to enhance multi-sector collaboration, such community health improvement (CHI) processes have the potential to bridge efforts of the health care delivery sector, public health agencies, and community organizations to improve population health. Having a shared measurement system is critical to achieving collective impact, yet despite the availability of community-level data from a variety of sources, many CHI processes lack clear, measurable objectives and evaluation plans. Through an in-depth analysis of ten exemplary CHI processes, we sought to identify best practices for population health measurement with a focus on monitoring collaborative implementation strategies.

Study design: Based on a review of the scientific literature, professional publications and presentations, and nominations from a national advisory panel, we identified 10 exemplary CHI processes. Criteria of choice were whether (1) the CHIs articulate a clear definition of intended outcomes; (2) clear, focused, measurable objectives and expected outcomes, including health equity; (3) expected outcomes are realistic and addressed with specific action plans; and (4) whether the plans and their associated performance measures become fully integrated into agencies and become a way of being for the agencies. We then conducted an in-depth analysis of CHNA, IS, and related documents created by health departments and leading hospitals in each process.

Population studied: U.S. hospitals.

Principal findings: Community health improvement processes benefit from a shared measurement system that indicate accountability for specific activities. Despite the importance of measurement and evaluation, existing community health improvement efforts often fall short in these areas. There is more variability in format and content of ISs than CHNAs; the most developed models include population-level goals/objectives and strategies with clear accountability and metrics. Other hospital IS's are less developed.Although all U.S. hospitals are familiar with performance measurement in their management, this familiarity does not seem to carry over to Community Benefit and CHNA efforts. Indeed, 5 of the 10 CHI processes we examined have some Accountable Care Organization (ACO) involvement, where population-health performance measures are commonplace. Yet this involvement is not mentioned in the CHNAs and ISs, nor are ACO data cited.

Conclusions: Strengthening the CHNA regulations to require that hospitals report the evaluation measures they intend to monitor based on an established community health improvement model could help commu

研究目标:非营利性医院需要与社区组织合作,制定社区卫生需求评估(CHNA)和实施战略(IS)。随着医疗保健提供系统从数量到价值的转变以及加强多部门合作的努力,这种社区健康改善(CHI)过程有可能弥合医疗保健提供部门、公共卫生机构和社区组织改善人口健康的努力。拥有一个共享的衡量系统对于实现集体影响至关重要,然而,尽管可以从各种来源获得社区层面的数据,但许多CHI过程缺乏明确、可衡量的目标和评估计划。通过对十个典型的CHI过程的深入分析,我们试图确定人口健康测量的最佳实践,重点是监测合作实施战略。研究设计:根据对科学文献、专业出版物和演示以及国家咨询小组的提名的审查,我们确定了10个典型的CHI过程。选择的标准是:(1)CHI是否明确定义了预期结果;(2) 明确、重点突出、可衡量的目标和预期成果,包括卫生公平;(3) 预期结果是现实的,并通过具体的行动计划加以解决;以及(4)计划及其相关绩效衡量标准是否完全融入各机构,并成为各机构的一种存在方式。然后,我们对CHNA、IS以及卫生部门和领先医院在每个过程中创建的相关文件进行了深入分析。研究人群:美国医院。主要发现:社区健康改善过程受益于一个表明对具体活动负责的共享衡量系统。尽管测量和评估很重要,但现有的社区卫生改善工作在这些领域往往不足。is的格式和内容比CHNA有更多的可变性;最发达的模型包括人口层面的目标/目的和具有明确问责制和衡量标准的战略。其他医院的IS则不太发达。尽管所有美国医院都熟悉其管理中的绩效衡量,但这种熟悉似乎并没有延续到社区福利和CHNA的努力中。事实上,在我们检查的10个CHI流程中,有5个流程有责任护理组织(ACO)的参与,在这些流程中,人口健康绩效指标很常见。然而,CHNA和is中没有提到这种参与,也没有引用ACO的数据。结论:加强CHNA法规,要求医院根据既定的社区健康改善模型报告他们打算监测的评估措施,可以帮助社区证明其影响。与医疗保健的其他领域一样,绩效指标应根据执行战略进行调整,并明确表明问责制,并从产出转向具有既定有效性和可靠性的过程和结果指标。对政策或实践的影响:尽管绩效衡量现在在整个医疗保健系统中很常见,但管理CHI流程的个人可能不太熟悉这种方法。这表明,重要的是要培养从业者有效使用it人口健康数据所需的知识和技能。
{"title":"Beyond CHNAS: Performance Measurement for Community Health Improvement.","authors":"Michael A Stoto,&nbsp;Mary V Davis,&nbsp;Abby Atkins","doi":"10.5334/egems.312","DOIUrl":"https://doi.org/10.5334/egems.312","url":null,"abstract":"<p><strong>Research objective: </strong>Non-profit hospitals are required to work with community organizations to prepare Community Health Needs Assessment (CHNA) and implementation strategy (IS). In concert with the health care delivery system's transformation from volume to value and efforts to enhance multi-sector collaboration, such community health improvement (CHI) processes have the potential to bridge efforts of the health care delivery sector, public health agencies, and community organizations to improve population health. Having a shared measurement system is critical to achieving collective impact, yet despite the availability of community-level data from a variety of sources, many CHI processes lack clear, measurable objectives and evaluation plans. Through an in-depth analysis of ten exemplary CHI processes, we sought to identify best practices for population health measurement with a focus on monitoring collaborative implementation strategies.</p><p><strong>Study design: </strong>Based on a review of the scientific literature, professional publications and presentations, and nominations from a national advisory panel, we identified 10 exemplary CHI processes. Criteria of choice were whether (1) the CHIs articulate a clear definition of intended outcomes; (2) clear, focused, measurable objectives and expected outcomes, including health equity; (3) expected outcomes are realistic and addressed with specific action plans; and (4) whether the plans and their associated performance measures become fully integrated into agencies and become a way of being for the agencies. We then conducted an in-depth analysis of CHNA, IS, and related documents created by health departments and leading hospitals in each process.</p><p><strong>Population studied: </strong>U.S. hospitals.</p><p><strong>Principal findings: </strong>Community health improvement processes benefit from a shared measurement system that indicate accountability for specific activities. Despite the importance of measurement and evaluation, existing community health improvement efforts often fall short in these areas. There is more variability in format and content of ISs than CHNAs; the most developed models include population-level goals/objectives and strategies with clear accountability and metrics. Other hospital IS's are less developed.Although all U.S. hospitals are familiar with performance measurement in their management, this familiarity does not seem to carry over to Community Benefit and CHNA efforts. Indeed, 5 of the 10 CHI processes we examined have some Accountable Care Organization (ACO) involvement, where population-health performance measures are commonplace. Yet this involvement is not mentioned in the CHNAs and ISs, nor are ACO data cited.</p><p><strong>Conclusions: </strong>Strengthening the CHNA regulations to require that hospitals report the evaluation measures they intend to monitor based on an established community health improvement model could help commu","PeriodicalId":72880,"journal":{"name":"EGEMS (Washington, DC)","volume":"7 1","pages":"45"},"PeriodicalIF":0.0,"publicationDate":"2019-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706995/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41221970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Making Better Use of Population Health Data for Community Health Needs Assessments. 更好地利用人口健康数据进行社区卫生需求评估。
Pub Date : 2019-08-20 DOI: 10.5334/egems.305
Michael A Stoto, Mary V Davis, Abby Atkins

Research objective: Non-profit hospitals are required to work with community organizations to prepare a Community Health Needs Assessment (CHNA) and implementation strategy (IS). In concert with the health care delivery system's transformation from volume to value and efforts to enhance multi-sector collaboration, such community health improvement (CHI) processes have the potential to bridge efforts of the health care delivery sector, public health agencies, and community organizations to improve population health. Having a shared measurement system is critical to achieving collective impact, yet despite the availability of community-level data from a variety of sources, many CHI processes lack clear, measurable objectives and evaluation plans. Through an in-depth analysis of ten exemplary CHI processes, we sought to identify best practices for population health measurement with a focus on measures for needs assessments and priority setting.

Study design: Based on a review of the scientific literature, professional publications and presentations, and nominations from a national advisory panel, we identified 10 exemplary CHI processes. Criteria of choice were whether (1) the CHIs articulate a clear definition of intended outcomes; (2) clear, focused, measurable objectives and expected outcomes, including health equity; (3) expected outcomes are realistic and addressed with specific action plans; and (4) whether the plans and their associated performance measures become fully integrated into agencies and become a way of being for the agencies. We then conducted an in-depth analysis of CHNA, IS, and related documents created by health departments and leading hospitals in each process.

Population studied: U.S. hospitals.

Principal findings: Census, American Community Survey, and similar data are available for smaller areas are used to describe the populations covered, and, to a lesser extent, to identify health issues where there are disparities and inequities.Common data sources for population health profiles, including risk factors and population health outcomes, are vital statistics, survey data including BRFSS, infectious disease surveillance data, hospital & ED data, and registries. These data are typically available only at the county level, and only occasionally are broken down by race, ethnicity, age, poverty.There is more variability in format and content of ISs than CHNAs; the most developed models include population-level goals/objectives and strategies with clear accountability and metrics. Other hospital IS's are less developed.

Conclusions: The county is the unit of choice because most population health profile data are not available for sub-county areas, but when a hospital serves a population more broadly or narrowly defined, appropriate data are not available to set priorities or monitor progress.Measure definitions are tak

研究目标:非营利性医院需要与社区组织合作,制定社区卫生需求评估(CHNA)和实施战略(IS)。随着医疗保健提供系统从数量到价值的转变以及加强多部门合作的努力,这种社区健康改善(CHI)过程有可能弥合医疗保健提供部门、公共卫生机构和社区组织改善人口健康的努力。拥有一个共享的衡量系统对于实现集体影响至关重要,然而,尽管可以从各种来源获得社区层面的数据,但许多CHI过程缺乏明确、可衡量的目标和评估计划。通过对十个典型的CHI过程的深入分析,我们试图确定人口健康测量的最佳实践,重点是需求评估和优先事项设定的措施。研究设计:根据对科学文献、专业出版物和演示以及国家咨询小组的提名的审查,我们确定了10个典型的CHI过程。选择的标准是:(1)CHI是否明确定义了预期结果;(2) 明确、重点突出、可衡量的目标和预期成果,包括卫生公平;(3) 预期结果是现实的,并通过具体的行动计划加以解决;以及(4)计划及其相关绩效衡量标准是否完全融入各机构,并成为各机构的一种存在方式。然后,我们对CHNA、IS以及卫生部门和领先医院在每个过程中创建的相关文件进行了深入分析。研究人群:美国医院。主要发现:人口普查、美国社区调查和较小地区的类似数据用于描述覆盖的人口,并在较小程度上用于确定存在差异和不平等的健康问题。人口健康状况的常见数据来源,包括风险因素和人口健康结果,包括生命统计、包括BRFSS在内的调查数据、传染病监测数据、医院和急诊数据以及登记册。这些数据通常只在县一级提供,偶尔也会按种族、民族、年龄和贫困程度进行细分。is的格式和内容比CHNA有更多的可变性;最发达的模型包括人口层面的目标/目的和具有明确问责制和衡量标准的战略。其他医院的IS则不太发达。结论:县是选择的单位,因为大多数人口健康状况数据都不适用于县以下地区,但当医院为更广泛或狭义的人群提供服务时,就无法获得适当的数据来设定优先事项或监测进展。度量定义取自原始数据源,因此很难在度量之间进行比较。因此,尽管CHNA涵盖了许多相同的主题,但所使用的措施差异很大。使用相同的社区健康状况,例如县健康排名,将简化基准测试和趋势分析。对政策或实践的影响:重要的是要制定人口健康数据,这些数据可以分解到适当的地理水平,并根据种族和民族、社会经济地位和其他与健康结果相关的因素来定义群体。
{"title":"Making Better Use of Population Health Data for Community Health Needs Assessments.","authors":"Michael A Stoto,&nbsp;Mary V Davis,&nbsp;Abby Atkins","doi":"10.5334/egems.305","DOIUrl":"https://doi.org/10.5334/egems.305","url":null,"abstract":"<p><strong>Research objective: </strong>Non-profit hospitals are required to work with community organizations to prepare a Community Health Needs Assessment (CHNA) and implementation strategy (IS). In concert with the health care delivery system's transformation from volume to value and efforts to enhance multi-sector collaboration, such community health improvement (CHI) processes have the potential to bridge efforts of the health care delivery sector, public health agencies, and community organizations to improve population health. Having a shared measurement system is critical to achieving collective impact, yet despite the availability of community-level data from a variety of sources, many CHI processes lack clear, measurable objectives and evaluation plans. Through an in-depth analysis of ten exemplary CHI processes, we sought to identify best practices for population health measurement with a focus on measures for needs assessments and priority setting.</p><p><strong>Study design: </strong>Based on a review of the scientific literature, professional publications and presentations, and nominations from a national advisory panel, we identified 10 exemplary CHI processes. Criteria of choice were whether (1) the CHIs articulate a clear definition of intended outcomes; (2) clear, focused, measurable objectives and expected outcomes, including health equity; (3) expected outcomes are realistic and addressed with specific action plans; and (4) whether the plans and their associated performance measures become fully integrated into agencies and become a way of being for the agencies. We then conducted an in-depth analysis of CHNA, IS, and related documents created by health departments and leading hospitals in each process.</p><p><strong>Population studied: </strong>U.S. hospitals.</p><p><strong>Principal findings: </strong>Census, American Community Survey, and similar data are available for smaller areas are used to describe the populations covered, and, to a lesser extent, to identify health issues where there are disparities and inequities.Common data sources for population health profiles, including risk factors and population health outcomes, are vital statistics, survey data including BRFSS, infectious disease surveillance data, hospital & ED data, and registries. These data are typically available only at the county level, and only occasionally are broken down by race, ethnicity, age, poverty.There is more variability in format and content of ISs than CHNAs; the most developed models include population-level goals/objectives and strategies with clear accountability and metrics. Other hospital IS's are less developed.</p><p><strong>Conclusions: </strong>The county is the unit of choice because most population health profile data are not available for sub-county areas, but when a hospital serves a population more broadly or narrowly defined, appropriate data are not available to set priorities or monitor progress.Measure definitions are tak","PeriodicalId":72880,"journal":{"name":"EGEMS (Washington, DC)","volume":"7 1","pages":"44"},"PeriodicalIF":0.0,"publicationDate":"2019-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706997/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41222008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Patient-Clinician Decision Making for Stable Angina: The Role of Health Literacy. 稳定型心绞痛的临床决策:健康素养的作用
Pub Date : 2019-08-09 DOI: 10.5334/egems.306
Samuel T Savitz, Claudia C Dobler, Nilay D Shah, Antonia V Bennett, Stacy Cooper Bailey, Stacie B Dusetzina, W Schuyler Jones, Sally C Stearns, Victor M Montori

Background: Stable angina patients have difficulty understanding the tradeoffs between treatment alternatives. In this analysis, we assessed treatment planning conversations for stable angina to determine whether inadequate health literacy acts as a barrier to communication that may partially explain this difficulty.

Methods: We conducted a descriptive analysis of patient questionnaire data from the PCI Choice Trial. The main outcomes were the responses to the Decisional Conflict Scale and the proportion of correct responses to knowledge questions about stable angina. We also conducted a qualitative analysis on recordings of patient-clinician discussions about treatment planning. The recordings were coded with the OPTION12 instrument for shared decision-making. Two analysts independently assessed the number and types of patient questions and expressions of preferences.

Results: Patient engagement did not differ by health literacy level and was generally low for all patients with respect to OPTION12 scores and the number of questions related to clinical aspects of treatment. Patients with inadequate health literacy had significantly higher decisional conflict. However, the proportion of knowledge questions answered correctly did not differ significantly by health literacy level.

Conclusions: Patients with inadequate health literacy had greater decisional conflict but no difference in knowledge compared to patients with adequate health literacy. Inadequate health literacy may act as a barrier to communication, but gaps were found in patient engagement and knowledge for patients of all health literacy levels. The recorded patient-clinician encounters and the health literacy measure were valuable resources for conducting research on care delivery.

背景:稳定型心绞痛患者很难理解治疗方案之间的权衡。在本分析中,我们评估了稳定型心绞痛的治疗计划对话,以确定健康素养不足是否成为沟通的障碍,这可能部分解释了这种困难。方法:我们对PCI选择试验的患者问卷数据进行了描述性分析。主要结果为对决策冲突量表的回答和对稳定型心绞痛知识问题的正确回答比例。我们还对医患讨论治疗计划的录音进行了定性分析。录音用OPTION12工具编码,以便共同决策。两名分析师独立评估了患者问题的数量和类型以及偏好的表达。结果:患者参与没有因健康素养水平而异,所有患者在OPTION12评分和与治疗临床方面相关的问题数量方面普遍较低。健康素养不足的患者有更高的决策冲突。然而,正确回答知识问题的比例在健康素养水平上没有显著差异。结论:健康素养不足的患者与健康素养充足的患者相比,存在更大的决策冲突,但在知识方面没有差异。卫生知识不足可能成为沟通的障碍,但在所有卫生知识水平的患者的参与和知识方面发现了差距。记录的患者与临床医生的接触和健康素养测量是开展护理提供研究的宝贵资源。
{"title":"Patient-Clinician Decision Making for Stable Angina: The Role of Health Literacy.","authors":"Samuel T Savitz, Claudia C Dobler, Nilay D Shah, Antonia V Bennett, Stacy Cooper Bailey, Stacie B Dusetzina, W Schuyler Jones, Sally C Stearns, Victor M Montori","doi":"10.5334/egems.306","DOIUrl":"10.5334/egems.306","url":null,"abstract":"<p><strong>Background: </strong>Stable angina patients have difficulty understanding the tradeoffs between treatment alternatives. In this analysis, we assessed treatment planning conversations for stable angina to determine whether inadequate health literacy acts as a barrier to communication that may partially explain this difficulty.</p><p><strong>Methods: </strong>We conducted a descriptive analysis of patient questionnaire data from the PCI Choice Trial. The main outcomes were the responses to the Decisional Conflict Scale and the proportion of correct responses to knowledge questions about stable angina. We also conducted a qualitative analysis on recordings of patient-clinician discussions about treatment planning. The recordings were coded with the OPTION12 instrument for shared decision-making. Two analysts independently assessed the number and types of patient questions and expressions of preferences.</p><p><strong>Results: </strong>Patient engagement did not differ by health literacy level and was generally low for all patients with respect to OPTION12 scores and the number of questions related to clinical aspects of treatment. Patients with inadequate health literacy had significantly higher decisional conflict. However, the proportion of knowledge questions answered correctly did not differ significantly by health literacy level.</p><p><strong>Conclusions: </strong>Patients with inadequate health literacy had greater decisional conflict but no difference in knowledge compared to patients with adequate health literacy. Inadequate health literacy may act as a barrier to communication, but gaps were found in patient engagement and knowledge for patients of all health literacy levels. The recorded patient-clinician encounters and the health literacy measure were valuable resources for conducting research on care delivery.</p>","PeriodicalId":72880,"journal":{"name":"EGEMS (Washington, DC)","volume":" ","pages":"42"},"PeriodicalIF":0.0,"publicationDate":"2019-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688543/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45836134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
EGEMS (Washington, DC)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1